| Mar 2, 2026 |
Mar 3, 2026 |
RUBIN PAUL D
|
Chief Medical Officer |
Sell |
11.3
|
-7,433
|
-100.00%
|
✓
|
$150.9K |
| Mar 1, 2026 |
Mar 3, 2026 |
GOLDSTEIN DOV A MD
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
RUBIN PAUL D
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
Morgen Eric
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
GOLDSTEIN DOV A MD
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
Fortney Kristen
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
Barton Shane
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 3, 2026 |
RUBIN PAUL D
|
Chief Medical Officer |
Sell |
11.3
|
-7,433
|
-100.00%
|
✓
|
$139.4K |
| Feb 1, 2026 |
Feb 3, 2026 |
GOLDSTEIN DOV A MD
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
GOLDSTEIN DOV A MD
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 13, 2026 |
Jan 15, 2026 |
GOLDSTEIN DOV A MD
|
CFO |
Sell |
10.0
|
-27,000
|
-54.65%
|
✓
|
$531.8K |
| Jan 13, 2026 |
Jan 15, 2026 |
Fortney Kristen
|
CEO |
Sell |
18.8
|
-233,107
|
-19.26%
|
✓
|
$4.2M |
| Jan 2, 2026 |
Jan 6, 2026 |
RUBIN PAUL D
|
Chief Medical Officer |
Sell |
11.3
|
-7,433
|
-100.00%
|
✓
|
$95.5K |
| Dec 9, 2025 |
Dec 11, 2025 |
RUBIN PAUL D
|
Chief Medical Officer |
Sell |
10.0
|
-18,000
|
-100.00%
|
✓
|
$216K |
| Dec 4, 2025 |
Dec 5, 2025 |
RUBIN PAUL D
|
Chief Medical Officer |
Sell |
7.5
|
-68,897
|
-100.00%
|
✓
|
$701.9K |
| Aug 7, 2025 |
Aug 11, 2025 |
Pande Vijay Satyanand
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2025 |
Jun 9, 2025 |
Hemrajani Rekha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2025 |
Jun 9, 2025 |
HEALY JAMES
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2025 |
Jun 9, 2025 |
ENRIGHT PATRICK G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2025 |
Jun 9, 2025 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2025 |
Jun 9, 2025 |
GARNIER JEAN PIERRE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 27, 2024 |
Mar 10, 2025 |
Hemrajani Rekha
|
Director |
Buy |
95.0
|
+3,000
|
100.00%
|
✗
|
$54K |
| Sep 27, 2024 |
Mar 10, 2025 |
Barton Shane
|
Principal Accounting Officer |
Buy |
91.3
|
+2,632
|
100.00%
|
✗
|
$47.4K |
| Feb 18, 2025 |
Feb 25, 2025 |
Morgen Eric
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 20, 2025 |
RUBIN PAUL D
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 20, 2025 |
Morgen Eric
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 20, 2025 |
GOLDSTEIN DOV A MD
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 20, 2025 |
Fortney Kristen
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 20, 2025 |
Barton Shane
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 18, 2024 |
Dec 20, 2024 |
Barton Shane
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2024 |
Oct 3, 2024 |
Pande Vijay Satyanand
|
Director |
Buy |
95.0
|
+219,195
|
7.27%
|
✗
|
$4.3M |
| Sep 27, 2024 |
Oct 1, 2024 |
Cormorant Asset Management, LP
|
Other |
Buy |
100.0
|
+450,000
|
38.15%
|
✗
|
$8.1M |
| Sep 27, 2024 |
Sep 27, 2024 |
Pande Vijay Satyanand
|
Director |
Buy |
100.0
|
+900,000
|
100.00%
|
✗
|
$16.2M |
| Sep 27, 2024 |
Sep 27, 2024 |
ENRIGHT PATRICK G
|
Director |
Buy |
100.0
|
+400,000
|
30.52%
|
✗
|
$7.2M |
| Sep 25, 2024 |
Sep 27, 2024 |
Fortney Kristen
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 27, 2024 |
Sep 27, 2024 |
HEALY JAMES
|
Director |
Buy |
100.0
|
+666,665
|
40.69%
|
✗
|
$12M |
| Sep 25, 2024 |
Sep 27, 2024 |
Hemrajani Rekha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 25, 2024 |
Sep 27, 2024 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 25, 2024 |
Sep 27, 2024 |
GARNIER JEAN PIERRE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 25, 2024 |
Sep 27, 2024 |
Morgen Eric
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Cormorant Asset Management, LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Pande Vijay Satyanand
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Hemrajani Rekha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
HEALY JAMES
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
ENRIGHT PATRICK G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
GARNIER JEAN PIERRE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
RUBIN PAUL D
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Morgen Eric
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
GOLDSTEIN DOV A MD
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Fortney Kristen
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 25, 2024 |
Barton Shane
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |